What is HUMA's current stock price?

HUMA is currently trading at $0.68 with a daily change of -13.21%. Visit StocksRunner for live updates.

What are HUMA stock's key strengths?

StocksRunner continuously monitors HUMA stock strengths including earnings trends, analyst upgrades, and sector momentum. Check the current analysis at stocksrunner.com/symbol/HUMA.

What are the risks associated with HUMA stock?

Current risk factors for HUMA include: Extreme. Risk levels are assessed by StocksRunner based on volatility, sector strength, volume, and investor confidence.

What is HUMA's current StocksRunner IQ Score?

HUMA current StocksRunner IQ Score is: Avoid. This score reflects aggregated earnings data, news sentiment, analyst ratings, and market momentum as of the latest update.

What factors influence HUMA's StocksRunner IQ Score?

HUMA StocksRunner IQ Score is a composite Credibility Score that weighs: quarterly earnings results vs. analyst expectations, breaking news sentiment and headline credibility, Wall Street analyst price target consensus, trading volume and price momentum, and sector-level risk indicators. All factors are aggregated in real time.

Market Overview Trending Stocks Stock Signals Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

HUMA Stock Analysis & IQ Rating | Humacyte

Q: Should I buy HUMA stock right now?

StocksRunner does not provide personalized investment advice. Our IQ Credibility Score for HUMA aggregates analyst sentiment, earnings performance, and news momentum to help you make an informed decision. The current IQ signal is: Avoid. Always consider your own risk tolerance and consult a financial advisor before investing.

Q: What does a Strong Buy rating mean for HUMA?

A Strong Buy rating on StocksRunner indicates that the aggregated IQ score — drawing from earnings beats, analyst upgrades, and positive news sentiment — reflects high confidence in HUMA near-term growth potential. It is the strongest signal in the StocksRunner IQ rating scale.

HUMA

Humacyte

$0.68

-$0.10 | -13.21%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Signals

52W High

$2.93

MKT CAP

$123.94M

52W Low

$0.67

VOL

$14.52M

P/E Ratio

N/A

AVG VOL

$7.45M

RSI

TREND

HUMA Stock IQ

Login to see Humacyte (HUMA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

HUMA Target Price

Login to display

HUMA Price Performance

$1.12 (-39.29%)

$0.96 (-29.17%)

$1.59 (-57.23%)

$1.53 (-55.56%)

1year

6month

3month

1month

HUMA Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

HUMA Analysts opinion is negative and it remained unchanged from the past 3 months

HUMA Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

64%

Consensus Rating

100%

Buy
Opinion

NA

Trend
Score

50%

Potential
Score

HUMA Street Sentiment is extremely bullish and have negative views on the near-term outlook

HUMA Risk Level

HUMA has Extreme risk level

Low-priced (<$5)

Near 52-week low

High beta (volatile)

High volatility

Extreme

LOW

HIGH

HUMA Performance Sentiment

Sentiments overview associated with events and the stock performance

64%

Positive

7 out of 11
events present

36%

Negative

4 out of 11
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$0.78

Resistance Price

$1.24

Current Price Range

$0.78

$1.24

Show methods +

Analyst Consensus

Recent Upgrades and Downgrades

100%

Consensus Rating

3

Buy

0

Hold

0

Sell

Date

Action

Rating

Firm

Dec 23, 2025

Reiterate

Buy

D. Boral Capital

Nov 21, 2025

Reiterate

Buy

BTIG

Nov 21, 2025

Reiterate

Buy

D. Boral Capital

Nov 14, 2025

Reiterate

Buy

Benchmark

Nov 13, 2025

Reiterate

Buy

D. Boral Capital

HUMA Trading Signals +

FAQ About HUMA Stock Insights

What is HUMA current stock price?

What are HUMA stock strengths?

What is HUMA Risk Level?

What is HUMA market cap and volume?

What is HUMA current Stock IQ?

Should I buy HUMA stock right now?

Is HUMA a Strong Buy right now?

What does a 'Strong Buy' rating mean for HUMA?

What does a 'Strong Sell' rating mean for HUMA?

What factors influence HUMA's Stock IQ?

Explore our HUMA Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored HUMA Stock Strategies
Effective Risk Management

FIND US ON

Receive our HUMA Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

HUMA

Humacyte

Set Alerts

Current Price

$0.68

-$0.10 | -13.21%

52W High

$2.93

MKT CAP

$123.94M

52W Low

$0.67

VOL

$14.52M

P/E Ratio

N/A

AVG VOL

$7.45M

RSI

TREND

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

HUMA Price Performance

$1.12 (-39.29%)

$0.96 (-29.17%)

$1.59 (-57.23%)

$1.53 (-55.56%)

1year

6month

3month

1month

HUMA Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

HUMA Analysts opinion is negative and it remained unchanged from the past 3 months

HUMA Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

64%

Consensus Rating

100%

Buy
Opinion

NA

Trend
Score

50%

Potential
Score

HUMA Street Sentiment is extremely bullish and have negative views on the near-term outlook

HUMA Risk Level

HUMA has Extreme risk level

Low-priced (<$5)

Near 52-week low

High beta (volatile)

High volatility

Extreme

LOW

HIGH

HUMA Performance Sentiment

Sentiments overview associated with events and the stock performance.

64%

Positive

7 out of 11
events present

36%

Negative

4 out of 11
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price

$0.78

Resistance Price

$1.24

Current Price Range

$0.78

$1.24

Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%

Consensus Rating

3

Buy

0

Hold

0

Sell

Date

Action

Rating

Firm

Dec 23, 2025

Reiterate

Buy

D. Boral Capital

Nov 21, 2025

Reiterate

Buy

BTIG

Nov 21, 2025

Reiterate

Buy

D. Boral Capital

Nov 14, 2025

Reiterate

Buy

Benchmark

Nov 13, 2025

Reiterate

Buy

D. Boral Capital

HUMA Stock IQ

Login to unlock Humacyte (HUMA) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Target Price

Login to display

Stock Insights

Not Enough Information

HUMA Trading Signals

Price Change % Bearish

HUMA is now at $0.68, down -13.21% from $0.78. This rapid movement warrants attention.

Near 52-Week High/Low Neutral

HUMA at $0.68 is within 1.49% of its 52-week low of $0.67. This proximity suggests potential reversal zone ahead.

High Volatility Neutral

HUMA is showing high volatility with an intraday swing of 14.93% (High: $0.77, Low: $0.67). This signals potential risk.

Earnings Announcement Bearish

HUMA has negative earnings news: Missed Estimate. Humacyte Inc. (HUMA) Reports Q4 Loss Misses Revenue Estimates. Humacyte Inc. (HUMA) delivered earnings and revenue surprises of -4.00% and -70.44% r...

Earnings Announcement Bearish

HUMA has negative earnings news: Loss Widens. Humacyte Posts Wider Q4 Loss Stock Falls 7%. (RTTNews) - Humacyte Inc. (HUMA) a biotechnology company focused on bioengineered human tissues announc...

Earnings Announcement Bearish

HUMA has negative earnings news: Weak Earnings. Earnings Scheduled For March 27 2026. Companies Reporting Before The Bell . Instil Bio (NASDAQ: TIL ) is expected to report earnings for its fourth...

Earnings Beat/Miss Bearish

HUMA missed earnings expectations. Humacyte Inc. (HUMA) Reports Q4 Loss Misses Revenue Estimates. Humacyte Inc. (HUMA) delivered earnings and revenue surprises of -4.00% and -70.44% r...

Breaking News Bullish

HUMA has breaking news: New Agreement. Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update. - Total revenues from sales and research colla...

Price Gap Up/Down Bearish

HUMA opened with a gap down of 5.13% (prev close $0.78, open $0.74)

MA20 Crossed MA50 Bearish

HUMA showing early bearish trend, price below MA20 (1.03) and MA20 below MA50 (1.05)

High Upside to Target Price Bullish

HUMA is trading 82.35% below analyst target price of $1.24, suggesting significant upside potential

Discover HUMA Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of HUMA. We're here to help you make informed investment decisions today.

FIND US ON

Receive our HUMA Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

HUMA Stock trends

HUMA Stock performance

HUMA Stock analysis

HUMA investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing HUMA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing HUMA

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.